You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海思科(002653.SZ):控股子公司擬對美國賽拉諾增資6300萬元
格隆匯 07-16 19:31

格隆匯 7 月 16日丨海思科(002653.SZ)公告,公司第四屆董事會第四次會議於2020年07月16日以通訊表決方式召開,會議通過了《關於控股子公司對其下屬子公司增資的議案》,現將相關事宜公告如下:

控股子公司對其下屬子公司增資事項概述:

(1)公司控股子公司成都賽拉諾醫療科技有限公司(以下簡稱“成都賽拉諾”)以自有資金對其全資子公司SILARAMEDTECHINC.(以下簡稱“美國賽拉諾”)增資900萬美元(摺合成人民幣約為6300萬元)。

(2)本次增資事項業經公司第四屆董事會第四次會議審議通過。根據相關法律法規、規範性文件及《公司章程》有關規定,該事項在董事會審批權限內,無需提交股東大會審議。

(3)本次增資不構成關聯交易,不構成《上市公司重大資產重組管理辦法》規定的重大資產重組。

增資目的、存在的風險及對公司的影響:

1、本次增資將用於美國賽拉諾日常運營及介入式心臟瓣膜的研發,有助於美國賽拉諾的穩定經營和中長期發展。

2、本次增資由成都賽拉諾自有資金解決,不會對公司財務及經營狀況產生重大不利影響,不存在損害公司及全體股東利益的情形。

3、本次增資同時也存在市場變化、子公司經營管理等風險,敬請廣大投資者注意投資風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account